Over 40 different nasal decolonization strategies have been tested over the past 60 years to eradicate MRSA in carrier patients. Intranasal administration of mupirocin (Bactroban ®) has some ...
Mupirocin (as calcium) 2%. Avoid eyes. Nasal use in high-risk patients: see full labeling regarding autoinfection. Discontinue if sensitization or severe local irritation occurs. Prolonged use may ...
suggests that of intranasal mupirocin can lower the infection rate in hospitalized patients, who test positive as nasal carriers of the Staphylococcus aureus bacteria, Up to 30 percent of people ...
Hosted on MSN1mon
Topical mupirocin lowers lupus inflammation, study findsMupirocin kills this type of bacteria. The study randomly selected systemic lupus erythematosus patients currently experiencing cutaneous lupus erythematosus flares to treat their skin lesions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results